Sustained increases in antibiotic prescriptions per primary care consultation for upper respiratory tract infections in England during the COVID-19 pandemic.
Journal
JAC-antimicrobial resistance
ISSN: 2632-1823
Titre abrégé: JAC Antimicrob Resist
Pays: England
ID NLM: 101765283
Informations de publication
Date de publication:
Feb 2023
Feb 2023
Historique:
received:
09
11
2022
accepted:
17
01
2023
entrez:
15
2
2023
pubmed:
16
2
2023
medline:
16
2
2023
Statut:
epublish
Résumé
The responsible use of existing antimicrobials is essential in reducing the threat posed by antimicrobial resistance (AMR). With the introduction of restrictions during the COVID-19 pandemic, a substantial reduction in face-to-face appointments in general practice was observed. To understand if this shift in healthcare provision has impacted on prescribing practices, we investigated antibiotic prescribing for upper respiratory tract infections (URTI) consultations. We conducted an interrupted time-series analysis using patient-level primary care data to assess the impact of the COVID-19 pandemic on consultations and antibiotic prescribing for URTI in England. We estimated an increase of 105.7 antibiotic items per 1000 URTI consultations (95% CI: 65.6-145.8; Overuse of antibiotics is known to be a driver of resistance and it is essential that efforts to reduce inappropriate prescribing continue subsequent to the COVID-19 pandemic. Further work should examine drivers of increased antibiotic prescribing for URTI to inform the development of targeted antibiotic stewardship interventions.
Sections du résumé
Background
UNASSIGNED
The responsible use of existing antimicrobials is essential in reducing the threat posed by antimicrobial resistance (AMR). With the introduction of restrictions during the COVID-19 pandemic, a substantial reduction in face-to-face appointments in general practice was observed. To understand if this shift in healthcare provision has impacted on prescribing practices, we investigated antibiotic prescribing for upper respiratory tract infections (URTI) consultations.
Methods
UNASSIGNED
We conducted an interrupted time-series analysis using patient-level primary care data to assess the impact of the COVID-19 pandemic on consultations and antibiotic prescribing for URTI in England.
Results
UNASSIGNED
We estimated an increase of 105.7 antibiotic items per 1000 URTI consultations (95% CI: 65.6-145.8;
Conclusions
UNASSIGNED
Overuse of antibiotics is known to be a driver of resistance and it is essential that efforts to reduce inappropriate prescribing continue subsequent to the COVID-19 pandemic. Further work should examine drivers of increased antibiotic prescribing for URTI to inform the development of targeted antibiotic stewardship interventions.
Identifiants
pubmed: 36789176
doi: 10.1093/jacamr/dlad012
pii: dlad012
pmc: PMC9921722
doi:
Types de publication
Journal Article
Langues
eng
Pagination
dlad012Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.
Références
J Antimicrob Chemother. 2018 Feb 1;73(suppl_2):ii36-ii43
pubmed: 29490058
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
J Antimicrob Chemother. 2022 Feb 23;77(3):799-802
pubmed: 34897486
JAMA Intern Med. 2013 Jan 14;173(1):72-4
pubmed: 23403816
Lancet Infect Dis. 2021 Jun;21(6):e144
pubmed: 33275941
Clin Microbiol Infect. 2021 Feb 16;:
pubmed: 33601010
J Hosp Infect. 2019 Apr;101(4):426-427
pubmed: 30826342
Bioorg Med Chem. 2016 Dec 15;24(24):6440-6445
pubmed: 27117692
Microbiology (Reading). 2010 Nov;156(Pt 11):3216-3223
pubmed: 20705661
Br J Gen Pract. 2021 Apr 29;71(706):e331-e338
pubmed: 33690150
Microbiol Mol Biol Rev. 2010 Sep;74(3):417-33
pubmed: 20805405
Health Policy. 2017 Oct;121(10):1025-1030
pubmed: 28888660